Metropolitan General Hospital
Athens 15562
1 studies enrolling now · 3 studies all time
What they study most
Breast Cancer, First Line Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Studies at this site
- Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients — Recruiting now
- Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1) — Running, not enrolling
- Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed